Washington, DC, United States of America

David W LaFleur

This inventor holds 20 USPTO granted patents and 7 published patent applications. Top assignee: Human Genome Sciences, Inc.. Active years: 2002-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David W LaFleur. Retrieved from https://idiyas.com/inventor/david-w-lafleur

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 50.0

Average Co-Inventor Count = 4.5

ph-index = 10

Forward Citations = 235(Granted Patents)


Company Filing History:


Years Active: 2002-2015

Loading Chart...
20 patents (USPTO):Explore Patents

Title: The Innovative Journey of David W LaFleur

Introduction: David W LaFleur is a distinguished inventor based in Washington, DC, known for his groundbreaking contributions to various fields through his inventive spirit and dedication to innovation.

Latest Patents: David W LaFleur's latest patents showcase his commitment to pushing the boundaries of technology and creativity, with a focus on improving everyday life through his inventions.

Career Highlights: Throughout his illustrious career, David W LaFleur has consistently demonstrated his prowess in inventing novel solutions to complex problems, earning him a reputation as a visionary in the world of innovation.

Collaborations: David W LaFleur has collaborated with leading experts in the industry, leveraging their collective knowledge and expertise to bring revolutionary ideas to life and make a lasting impact on society.

Conclusion: David W LaFleur's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of inventors, leaving an indelible mark on the landscape of modern technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…